Merial launches IMRAB 3 TF in individual-dose packages.
Merial launches IMRAB3 TF in individual-dose packages. This newly licensed product will better meet the needs of veterinary professionals and the growing demand for IMRAB3, the company says. The pharmaceutical manufacturer changed the products label to reflect its thimerosal-free status. The relicensed product was made available to veterinarians in the United States in January. We are adding TF to designate thimerosol-free on the vaccine label because it helps to differentiate this product from the IMRAB3 multi-dose vials, says Dr. Zack Mills, brand director of Merials vaccine group. Merial wants veterinarians to have alternatives when choosing the best medicine for their patients. IMRAB3 gives the practitioner a thimerosal-free alternative rabies vaccine for dogs, cats and ferrets.Thimerosal, which contains mercury, has been used since the 1930s as a preservative in many drugs and vaccines. It has both antibacterial and anti-fungal properties.
For fastest response call (888) 637-4251 or visit the Web site at www.merial.com.